INmune Bio Inc (INMB) — Financial Flexibility Index
INmune Bio Inc (INMB) has a Financial Flexibility Index of -0.95x as of June 2026. Free cash flow of $-6.15 Million (operating CF $-6.58 Million minus capex $430.00K) represents -1% of total liabilities ($6.48 Million). Check INMB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INmune Bio Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for INmune Bio Inc across 11 annual periods. For the full cash flow conversion analysis, see INMB operating cash flow.
Annual Financial Flexibility Index for INmune Bio Inc (2015–2025)
Year-by-year free cash flow to debt coverage for INmune Bio Inc. Explore cash flow to debt ratio of INmune Bio Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-21.54 Million | $-22.58 Million | $8.83 Million | ▲ +45.4% |
| 2024 | -4.47x | $-33.36 Million | $-33.36 Million | $7.46 Million | ▼ -603.6% |
| 2023 | -0.64x | $-11.98 Million | $-11.98 Million | $18.86 Million | ▲ +39.3% |
| 2022 | -1.05x | $-22.69 Million | $-22.69 Million | $21.69 Million | ▼ -52.7% |
| 2021 | -0.68x | $-13.50 Million | $-28.50 Million | $19.72 Million | ▲ +85.4% |
| 2020 | -4.70x | $-8.94 Million | $-8.94 Million | $1.90 Million | ▲ +24.9% |
| 2019 | -6.26x | $-5.38 Million | $-5.38 Million | $860.54K | ▼ -150.3% |
| 2018 | -2.50x | $-2.06 Million | $-2.06 Million | $823.77K | ▼ -17.0% |
| 2017 | -2.14x | $-661.83K | $-761.83K | $309.72K | ▼ -304.5% |
| 2016 | -0.53x | $-317.38K | $-317.38K | $600.81K | ▲ +10.3% |
| 2015 | -0.59x | $-18.12K | $-18.12K | $30.75K | — |